IMNM
Price
$9.12
Change
+$0.10 (+1.11%)
Updated
Jun 5 closing price
Capitalization
793.99M
68 days until earnings call
NGNE
Price
$22.92
Change
+$1.25 (+5.77%)
Updated
Jun 5 closing price
Capitalization
327.6M
Interact to see
Advertisement

IMNM vs NGNE

Header iconIMNM vs NGNE Comparison
Open Charts IMNM vs NGNEBanner chart's image
Immunome
Price$9.12
Change+$0.10 (+1.11%)
Volume$563.93K
Capitalization793.99M
Neurogene
Price$22.92
Change+$1.25 (+5.77%)
Volume$335.62K
Capitalization327.6M
IMNM vs NGNE Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. NGNE commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and NGNE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (IMNM: $9.13 vs. NGNE: $22.97)
Brand notoriety: IMNM and NGNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 55% vs. NGNE: 108%
Market capitalization -- IMNM: $793.99M vs. NGNE: $327.6M
IMNM [@Biotechnology] is valued at $793.99M. NGNE’s [@Biotechnology] market capitalization is $327.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 7 TA indicator(s) are bullish while NGNE’s TA Score has 6 bullish TA indicator(s).

  • IMNM’s TA Score: 7 bullish, 3 bearish.
  • NGNE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than NGNE.

Price Growth

IMNM (@Biotechnology) experienced а +1.96% price change this week, while NGNE (@Biotechnology) price change was +22.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

NGNE is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($794M) has a higher market cap than NGNE($328M). NGNE YTD gains are higher at: 0.481 vs. IMNM (-14.077). NGNE has higher annual earnings (EBITDA): -77.68M vs. IMNM (-109.95M). NGNE has more cash in the bank: 293M vs. IMNM (240M). IMNM has less debt than NGNE: IMNM (2.72M) vs NGNE (13.5M). IMNM has higher revenues than NGNE: IMNM (10.1M) vs NGNE (925K).
IMNMNGNEIMNM / NGNE
Capitalization794M328M242%
EBITDA-109.95M-77.68M142%
Gain YTD-14.0770.481-2,926%
P/E RatioN/AN/A-
Revenue10.1M925K1,092%
Total Cash240M293M82%
Total Debt2.72M13.5M20%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMNGNE
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend about 1 month ago
87%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USEMX22.48N/A
N/A
Victory Emerging Markets
INRSX16.78N/A
N/A
Macquarie Natural Resources R6
FAPHX12.98N/A
N/A
Fidelity Healthy Future
IVIFX20.91N/A
N/A
Macquarie International Core Eq C
VGRIX78.36N/A
N/A
JPMorgan US Value A

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.16%
IDYA - IMNM
60%
Loosely correlated
-0.09%
BEAM - IMNM
55%
Loosely correlated
-0.87%
RXRX - IMNM
55%
Loosely correlated
-7.13%
SYRE - IMNM
54%
Loosely correlated
+0.54%
TRDA - IMNM
52%
Loosely correlated
+2.14%
More

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+6.00%
BRNS - NGNE
51%
Loosely correlated
-8.33%
RNAZ - NGNE
48%
Loosely correlated
-1.89%
ZNTL - NGNE
47%
Loosely correlated
-2.00%
SNDX - NGNE
45%
Loosely correlated
+1.82%
IRON - NGNE
43%
Loosely correlated
+1.39%
More